We are live on ! Find out more
PPHMP

Peregrine Pharmaceuticals Inc. 10.50% Series E Convertible
PPHMP

Delisted

PPHMP was delisted on the 5th of January, 2018.

Back to rankings

1 hedge funds and large institutions have $13K invested in Peregrine Pharmaceuticals Inc. 10.50% Series E Convertible in 2016 Q3 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

30% more capital invested

Capital invested by funds: $10K → $13K (+$3K)

0% more funds holding

Funds holding: 1 → 1 (0)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
BWA
1
Burt Wealth Advisors
Maryland
$13K – – –

PPHMP Hedge Fund Activity: Q3 2016 in Review

1 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Peregrine Pharmaceuticals Inc. 10.50% Series E Convertible (PPHMP) for Q3 2016, worth a combined $13K — up 30% from $10K a quarter earlier.

Fund positioning in PPHMP was balanced in Q3 2016: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held Peregrine Pharmaceuticals Inc. 10.50% Series E Convertible (PPHMP) as of Q3 2016, unchanged from Q2 2016.
  • Funds reported $13K of Peregrine Pharmaceuticals Inc. 10.50% Series E Convertible stock for Q3 2016, up 30% quarter-over-quarter.
  • 0 funds opened new Peregrine Pharmaceuticals Inc. 10.50% Series E Convertible positions in Q3 2016 and 0 closed out.

Based on aggregated 13F filings for Q3 2016.